{"name":"Shanghai Juncell Therapeutics","slug":"shanghai-juncell-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GC101 TIL","genericName":"GC101 TIL","slug":"gc101-til","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"GC101 TIL","genericName":"GC101 TIL","slug":"gc101-til","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQT0hqVWdKQlhHVkl0NnRHakxSakZjN1ZfSlBjRFBYRFlYdkpHVTdRSXdpWUs5VVRxSXZLU2ZXcXZLNDYtOFZXV2g0dGVoRTRtRV9WN1FEbGZqTy1USHk2TkRqblAzdVFiNEFzX0MtZWg3RVZURFN0UHlyeFRybVRFYlNQQmxneDRZeUN3NTFJZlVJQW55OTNGUkdORzNCeWFZbkhVSFlR?oc=5","date":"2025-01-23","type":"regulatory","source":"globaldata.com","summary":"Likelihood of Approval and Phase Transition Success Rate Model – GC-203 in Endometrial Cancer - globaldata.com","headline":"Likelihood of Approval and Phase Transition Success Rate Model – GC-203 in Endometrial Cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPMjBNNUpIaWFsbm5fNnlNQjIyOC1yNVZwUks5MU1DZHhycVAyY18yTHQyblY0bWwxeWNhZFd6aFRDSTlfOGdnb2I0VWVhWDJEMnNQZ0ZQRHVWZGhpSGQxME9aY2p4bVNWWFV0eDJScmJ0TmNNUlczMnN4Q1VTaVppV3V2eGE5dmpoVlBBOE93Q0lYclUtR3g4TlpxOUUzV0pnc005ck9OTS1kMi1uLUdTZl9HeUxySWhvN3NNVWVJZWJ5RVE0TEJrVDVYTQ?oc=5","date":"2024-12-20","type":"pipeline","source":"BioSpectrum Asia","summary":"Juncell Therapeutics opens state-of-the-art facility for TIL production in China - BioSpectrum Asia","headline":"Juncell Therapeutics opens state-of-the-art facility for TIL production in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOSHNiMFJsdFVkcndZQXg5WUU4ZG5DYmxzd2REZGJlcWFYLUdOendFZUZlWkF6dTlPUnVhSTdDcDBxclBzUDVjcm5obW82cmlrY1Y2Y3A5UzA4bU91enJGMk1EV1Nxb0lJR3h0d1ZwUWpYbThiU3Y0Z0dtMnk4MTI4VDY5ODNBWTc2TVpMT1pULTZlV3Y4MUFJcWtSc3phbUg0UFl6NDcwNG16QUtmZUZYQTFCbml2dUlRUlpJTlpEUG1VS3UxUTZmRWp6UDYxeTBELVQ0bElFVlg1WTZaT1NxdlhIS1NSRjlkWXlVZmtWQjNhVzVheDYxNDdqVGlTeFk?oc=5","date":"2024-12-19","type":"pipeline","source":"BioPharma APAC","summary":"Shanghai’s Juncell Therapeutics Opens State-of-the-Art TIL Manufacturing Facility at Anting International Medical Industry Park - BioPharma APAC","headline":"Shanghai’s Juncell Therapeutics Opens State-of-the-Art TIL Manufacturing Facility at Anting International Medical Indust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRExvMGNscDdPU1EycFZYOC1OY2Q1VlI5OTZGNEtqc1N1TUlJaW1jbnFsZ1UxbjN0MkRfV0J4aHd3a1NuMjJ4NFY4QmZpMGhLUWNraEZvMGZpa20tTVlqdnJJNEZjRVFoRFZSeG9USVVUSDk4Uk1DbHNGVHpxemFPWjNWSHNxaGo3UFRBWEVpTl9EVHh4RDNvNmlOQXg4MmdNcjNtWWlR?oc=5","date":"2024-12-18","type":"pipeline","source":"Contract Pharma","summary":"Juncell Therapeutics Opens New TIL Manufacturing Facility - Contract Pharma","headline":"Juncell Therapeutics Opens New TIL Manufacturing Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9kclpndzZyNGVlY0Z5TGlzRXdxdWpzMzgySFBpYTJ0NW0wcnprRFNHU3dRX21fbkVOVkdrdHlROGZuVm1Cbzh6NUtEakF3NkR0SFowTGEtOTdiMXFBYTcwTGpxeU14Wmpick1RVDhjTDhIZw?oc=5","date":"2024-10-14","type":"trial","source":"Oncology Pipeline","summary":"No easy ride for Turnstone | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"No easy ride for Turnstone | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}